Silo Wellness to Create a Psychedelic Pharmaceutical Manufacturing and Research Portfolio with Proposed Acquisition of Dyscovry Science
Ryan Allway May 31st, 2022 Psychedelics, Top News Toronto, Ontario–(Newsfile Corp. – May 31, 2022) – Silo Wellness Inc. (CSE: SILO) (OTCQB: SILFF) (FSE: 3K70) (“Silo Wellness” or the “Company“), a leading global psychedelics company, is pleased to announce that it has executed a nonbinding letter of intent to... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )